These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The effect of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (pentoxifyllin) on the cardiovascular system of the dog]. Komarek J, Sakurai M. Arzneimittelforschung; 1974 May; 24(5):781-3. PubMed ID: 4408132 [No Abstract] [Full Text] [Related]
13. [Influence of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine on alpha-adrenergic effects]. Boksay I, Bollmann V, Popendiker K. Arzneimittelforschung; 1971 Aug; 21(8):1174-7. PubMed ID: 5110013 [No Abstract] [Full Text] [Related]
14. Cardiovascular effects of synthetic physalaemin. Nakano J, Darrow BA, McCurdy JR. Arch Int Pharmacodyn Ther; 1968 Apr; 172(2):429-34. PubMed ID: 5684254 [No Abstract] [Full Text] [Related]
15. [Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)]. Vater W, Kroneberg G, Hoffmeister F, Saller H, Meng K, Oberdorf A, Puls W, Schlossmann K, Stoepel K. Arzneimittelforschung; 1972 Jan; 22(1):1-14. PubMed ID: 4622472 [No Abstract] [Full Text] [Related]
16. Proceedings: Review of the cardiovascular pharmacology of perhexiline. Hudak WJ, Lewis RE, Lucas RW, Kuhn WL. Postgrad Med J; 1973 Apr; 49():Suppl 3:16-25. PubMed ID: 4202743 [No Abstract] [Full Text] [Related]
19. [Pharmacology of a new anti-angina preparation, nonachlazin]. Kaverdina NV, Markova GA. Farmakol Toksikol; 1975 Apr; 38(2):173-7. PubMed ID: 1227883 [Abstract] [Full Text] [Related]
20. Coronary circulation systemic resistance and capacitance blood vessels of dogs as affected by BAY a 1040. Hirakawa S, Ito H, Kondo Y, Watanabe I, Hiei K. Arzneimittelforschung; 1972 Feb; 22(2):344-9. PubMed ID: 4623698 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]